Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '584 patent appeal question...

TPL Files Appeal of '584 patent to reverse Markman ruling.. Arm accused of infringing MMP patents

Leckrone Asserts "Misleading ARM News Release"

Leckrone noted that ARM issued a news release on September 20, 2007 that was misleading in that it implied the Texas Court somehow passed a judgment of non-infringement in favor of ARM. In point of fact, it was TPL who initiated the partial non-infringement stipulation to pave the way for a speedier trial and TPLs opportunity to appeal the single Markman ruling on the instruction groups claims construction. He declared, The fact that TPL gave ARM a judgment of non-infringement was purely procedural as well as temporary until the reversal of the US 584 ruling.

According to Leckrone, all ARM core families (ARM7, ARM9, ARM9E, ARM10E, ARM11) and the ARM Cortex microprocessor core family do infringe upon the US 584 as well as US 5,440,749 in the MMP Portfolio. He warned that all manufacturers of end user products using infringing ARM processors with the exception of the 20 global manufacturers who have already purchased MMP Portfolio licenses are infringers of technology protected by the MMP Portfolio. The longer infringers wait to purchase an MMP license, the more they can expect to pay because our program is designed to reward first-movers in various industry categories.

http://www.smartbrief.com/news/aaaa/industryBW-detail.jsp?id=F04AB19B-DF2B-44B1-BD96-FA8CAA31F8F4

Share
New Message
Please login to post a reply